- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
The global Infectious Diseases Diagnostic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Diseases Diagnostic.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Infectious Diseases Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Diseases Diagnostic market by product type and applications/end industries.
Market Segment by Companies, this report covers
Becton Dickinson & Company
Roche Diagnostics
bioMerieux SA
Cepheid, Inc.
Thermo Fisher Scientific, Inc.
Abbott Laboratories
DiaSorin S.p.A.
Danaher Corporation
Hologic, Inc.
Alera Inc.
Quidel Corporation
Bio-Rad Laboratories, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Urine
Blood
Others
Market Segment by Applications, can be divided into
Hospitals and Trauma Centers
Diagnostic Laboratories
Rehabilitation Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Infectious Diseases Diagnostic Market Overview
1.1 Product Overview and Scope of Infectious Diseases Diagnostic
1.2 Classification of Infectious Diseases Diagnostic by Types
1.2.1 Global Infectious Diseases Diagnostic Revenue Comparison by Types (2019-2024)
1.2.2 Global Infectious Diseases Diagnostic Revenue Market Share by Types in 2018
1.2.3 Urine
1.2.4 Blood
1.2.5 Others
1.3 Global Infectious Diseases Diagnostic Market by Application
1.3.1 Global Infectious Diseases Diagnostic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals and Trauma Centers
1.3.3 Diagnostic Laboratories
1.3.4 Rehabilitation Centers
1.4 Global Infectious Diseases Diagnostic Market by Regions
1.4.1 Global Infectious Diseases Diagnostic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Infectious Diseases Diagnostic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Infectious Diseases Diagnostic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Diseases Diagnostic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Infectious Diseases Diagnostic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Diseases Diagnostic Status and Prospect (2014-2024)
1.5 Global Market Size of Infectious Diseases Diagnostic (2014-2024)
2 Company Profiles
2.1 Becton Dickinson & Company
2.1.1 Business Overview
2.1.2 Infectious Diseases Diagnostic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche Diagnostics
2.2.1 Business Overview
2.2.2 Infectious Diseases Diagnostic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Diagnostics Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.3 bioMerieux SA
2.3.1 Business Overview
2.3.2 Infectious Diseases Diagnostic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 bioMerieux SA Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Cepheid, Inc.
2.4.1 Business Overview
2.4.2 Infectious Diseases Diagnostic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cepheid, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Thermo Fisher Scientific, Inc.
2.5.1 Business Overview
2.5.2 Infectious Diseases Diagnostic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Abbott Laboratories
2.6.1 Business Overview
2.6.2 Infectious Diseases Diagnostic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.7 DiaSorin S.p.A.
2.7.1 Business Overview
2.7.2 Infectious Diseases Diagnostic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.8 Danaher Corporation
2.8.1 Business Overview
2.8.2 Infectious Diseases Diagnostic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Danaher Corporation Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hologic, Inc.
2.9.1 Business Overview
2.9.2 Infectious Diseases Diagnostic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hologic, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.10 Alera Inc.
2.10.1 Business Overview
2.10.2 Infectious Diseases Diagnostic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Alera Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.11 Quidel Corporation
2.11.1 Business Overview
2.11.2 Infectious Diseases Diagnostic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Quidel Corporation Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Business Overview
2.12.2 Infectious Diseases Diagnostic Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
3 Global Infectious Diseases Diagnostic Market Competition, by Players
3.1 Global Infectious Diseases Diagnostic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Infectious Diseases Diagnostic Players Market Share
3.2.2 Top 10 Infectious Diseases Diagnostic Players Market Share
3.3 Market Competition Trend
4 Global Infectious Diseases Diagnostic Market Size by Regions
4.1 Global Infectious Diseases Diagnostic Revenue and Market Share by Regions
4.2 North America Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
4.3 Europe Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
4.5 South America Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
5 North America Infectious Diseases Diagnostic Revenue by Countries
5.1 North America Infectious Diseases Diagnostic Revenue by Countries (2014-2019)
5.2 USA Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
5.3 Canada Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
5.4 Mexico Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
6 Europe Infectious Diseases Diagnostic Revenue by Countries
6.1 Europe Infectious Diseases Diagnostic Revenue by Countries (2014-2019)
6.2 Germany Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
6.3 UK Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
6.4 France Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
6.5 Russia Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
6.6 Italy Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Infectious Diseases Diagnostic Revenue by Countries
7.1 Asia-Pacific Infectious Diseases Diagnostic Revenue by Countries (2014-2019)
7.2 China Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
7.3 Japan Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
7.4 Korea Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
7.5 India Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
8 South America Infectious Diseases Diagnostic Revenue by Countries
8.1 South America Infectious Diseases Diagnostic Revenue by Countries (2014-2019)
8.2 Brazil Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
8.3 Argentina Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
8.4 Colombia Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Infectious Diseases Diagnostic by Countries
9.1 Middle East and Africa Infectious Diseases Diagnostic Revenue by Countries (2014-2019)
9.2 Saudi Arabia Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
9.3 UAE Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
9.4 Egypt Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
9.5 Nigeria Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
9.6 South Africa Infectious Diseases Diagnostic Revenue and Growth Rate (2014-2019)
10 Global Infectious Diseases Diagnostic Market Segment by Type
10.1 Global Infectious Diseases Diagnostic Revenue and Market Share by Type (2014-2019)
10.2 Global Infectious Diseases Diagnostic Market Forecast by Type (2019-2024)
10.3 Urine Revenue Growth Rate (2014-2024)
10.4 Blood Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Infectious Diseases Diagnostic Market Segment by Application
11.1 Global Infectious Diseases Diagnostic Revenue Market Share by Application (2014-2019)
11.2 Infectious Diseases Diagnostic Market Forecast by Application (2019-2024)
11.3 Hospitals and Trauma Centers Revenue Growth (2014-2019)
11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
11.5 Rehabilitation Centers Revenue Growth (2014-2019)
12 Global Infectious Diseases Diagnostic Market Size Forecast (2019-2024)
12.1 Global Infectious Diseases Diagnostic Market Size Forecast (2019-2024)
12.2 Global Infectious Diseases Diagnostic Market Forecast by Regions (2019-2024)
12.3 North America Infectious Diseases Diagnostic Revenue Market Forecast (2019-2024)
12.4 Europe Infectious Diseases Diagnostic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Infectious Diseases Diagnostic Revenue Market Forecast (2019-2024)
12.6 South America Infectious Diseases Diagnostic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Infectious Diseases Diagnostic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Infectious Diseases Diagnostic Picture
Table Product Specifications of Infectious Diseases Diagnostic
Table Global Infectious Diseases Diagnostic and Revenue (Millio
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
